Literature DB >> 11097655

Assessing readmission to substance abuse treatment as an indicator of outcome and program performance.

K Humphreys1, K R Weingardt.   

Abstract

Managed health care systems often use treatment readmission data as an indicator of psychiatric patient outcome and program performance. This study of 3,018 inpatients being treated for substance abuse in Department of Veterans Affairs medical centers found that across a range of measures and patient subpopulations, patient outcomes and program performance were virtually independent of treatment readmission. These findings suggest that even though readmission for substance abuse treatment may have value as an easily obtainable measure of health care utilization and cost, it cannot serve as a valid substitute for direct assessment of patient outcome or program performance.

Entities:  

Mesh:

Year:  2000        PMID: 11097655     DOI: 10.1176/appi.ps.51.12.1568

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


  4 in total

1.  Outcomes for medicaid clients with substance abuse problems before and after managed care.

Authors:  Bentson H McFarland; Dennis D Deck; Lynn E McCamant; Roy M Gabriel; Douglas A Bigelow
Journal:  J Behav Health Serv Res       Date:  2005 Oct-Dec       Impact factor: 1.505

2.  Inpatient hospitalization in addiction treatment for patients with a history of suicide attempt: a case of support for treatment performance measures.

Authors:  Joseph E Glass; Mark A Ilgen; Jamie J Winters; Regan L Murray; Brian E Perron; Stephen T Chermack
Journal:  J Psychoactive Drugs       Date:  2010-09

3.  An examination of main and interactive effects of substance abuse recovery housing on multiple indicators of adjustment.

Authors:  Leonard A Jason; Bradley D Olson; Joseph R Ferrari; John M Majer; Josefina Alvarez; Jane Stout
Journal:  Addiction       Date:  2007-07       Impact factor: 6.526

4.  Patient-Level Predictors of Psychiatric Readmission in Substance Use Disorders.

Authors:  Volker Böckmann; Barbara Lay; Erich Seifritz; Wolfram Kawohl; Patrik Roser; Benedikt Habermeyer
Journal:  Front Psychiatry       Date:  2019-11-26       Impact factor: 4.157

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.